QVT Financial’s Investments, Performance, Letters

4. Arbutus Biopharma Corp (NASDAQ:ABUS)

In Arbutus Biopharma Corp (NASDAQ:ABUS), QVT Financial holds 16.01 million shares worth $57.65 million, also through Roivant Sciences. Arbutus Biopharma Corp (NASDAQ:ABUS) is a micro-cap biotech company that is engaged in developing Hepatitis B drugs. The company was formed in 2015 through the merger of Tekmira Pharmaceuticals and OnCore Biopharma. The company’s stock has climbed by over 70% since the beginning of the year, on better-than-expected results for the first two quarters. There were seven funds tracked by Insider Monkey long Arbutus Biopharma Corp (NASDAQ:ABUS) at the end of June.

Follow Arbutus Biopharma Corp (NASDAQ:ABUS)